| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 2.03e-04 | 65 | 89 | 4 | GO:0016706 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 2.88e-04 | 29 | 89 | 3 | GO:0005540 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 4.72e-04 | 310 | 89 | 7 | GO:0030246 | |
| GeneOntologyMolecularFunction | collagen binding | 4.72e-04 | 81 | 89 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 6.93e-04 | 9 | 89 | 2 | GO:0010854 | |
| GeneOntologyCellularComponent | lysosomal lumen | 6.55e-05 | 98 | 90 | 5 | GO:0043202 | |
| GeneOntologyCellularComponent | axon initial segment | 2.60e-04 | 29 | 90 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS12 ADAMTS10 SSC5D AEBP1 ADAMTS7 P3H1 NCAN C6orf15 ADAMTS17 BCAN | 5.17e-04 | 656 | 90 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS12 ADAMTS10 SSC5D AEBP1 ADAMTS7 P3H1 NCAN C6orf15 ADAMTS17 BCAN | 5.30e-04 | 658 | 90 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | main axon | 5.93e-04 | 89 | 90 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | perineuronal net | 8.07e-04 | 10 | 90 | 2 | GO:0072534 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 9.83e-04 | 11 | 90 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | vacuolar lumen | 1.04e-03 | 178 | 90 | 5 | GO:0005775 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.39e-03 | 13 | 90 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | centrosome | MYOF EPS8L2 PPP4C PROSER3 NR0B1 SCYL1 AKNA MAP3K11 BIRC7 WDR62 | 1.74e-03 | 770 | 90 | 10 | GO:0005813 |
| MousePheno | cochlear ganglion hypoplasia | 2.28e-05 | 11 | 74 | 3 | MP:0003637 | |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 2.89e-05 | 113 | 74 | 6 | MP:0000165 | |
| MousePheno | decreased length of long bones | 5.56e-05 | 409 | 74 | 10 | MP:0004686 | |
| MousePheno | small cochlear ganglion | 9.18e-05 | 17 | 74 | 3 | MP:0003986 | |
| MousePheno | axonal spheroids | 9.18e-05 | 17 | 74 | 3 | MP:0010047 | |
| MousePheno | axon degeneration | 1.18e-04 | 91 | 74 | 5 | MP:0005405 | |
| MousePheno | thick skin | 1.62e-04 | 52 | 74 | 4 | MP:0001200 | |
| MousePheno | increased collagen level | 1.65e-04 | 4 | 74 | 2 | MP:0020253 | |
| MousePheno | abnormal dermis reticular layer morphology | 1.65e-04 | 4 | 74 | 2 | MP:0005081 | |
| MousePheno | neurodegeneration | CSF1R MAP1A TECPR2 SCYL1 FUCA1 ADGRV1 MYO15A IDUA HSPB8 TBCE | 1.69e-04 | 468 | 74 | 10 | MP:0002229 |
| MousePheno | abnormal skin condition | 1.94e-04 | 227 | 74 | 7 | MP:0001191 | |
| MousePheno | abnormal long bone epiphyseal plate morphology | 2.95e-04 | 172 | 74 | 6 | MP:0003055 | |
| MousePheno | abnormal cartilage development | 2.95e-04 | 172 | 74 | 6 | MP:0000164 | |
| Domain | PLAC | 1.47e-06 | 19 | 85 | 4 | PS50900 | |
| Domain | PLAC | 1.47e-06 | 19 | 85 | 4 | IPR010909 | |
| Domain | ADAM_spacer1 | 3.31e-06 | 23 | 85 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 3.31e-06 | 23 | 85 | 4 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.96e-06 | 24 | 85 | 4 | IPR013273 | |
| Domain | Peptidase_M12B_N | 2.91e-05 | 39 | 85 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.91e-05 | 39 | 85 | 4 | PF01562 | |
| Domain | C_TYPE_LECTIN_1 | 3.19e-05 | 80 | 85 | 5 | PS00615 | |
| Domain | DISINTEGRIN_1 | 3.22e-05 | 40 | 85 | 4 | PS00427 | |
| Domain | Reprolysin | 3.22e-05 | 40 | 85 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 3.22e-05 | 40 | 85 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.22e-05 | 40 | 85 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 3.22e-05 | 40 | 85 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 3.56e-05 | 41 | 85 | 4 | IPR001762 | |
| Domain | Lectin_C | 4.04e-05 | 84 | 85 | 5 | PF00059 | |
| Domain | CLECT | 4.04e-05 | 84 | 85 | 5 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 4.27e-05 | 85 | 85 | 5 | PS50041 | |
| Domain | - | EPOR FLT4 CSF1R NFATC4 AXL ICAM5 NCAN OBSCN ROBO2 BCAN IFNLR1 CNTFR | 4.45e-05 | 663 | 85 | 12 | 2.60.40.10 |
| Domain | C-type_lectin-like | 4.52e-05 | 86 | 85 | 5 | IPR001304 | |
| Domain | - | 8.04e-05 | 97 | 85 | 5 | 3.10.100.10 | |
| Domain | Ig-like_fold | EPOR FLT4 CSF1R NFATC4 AXL ICAM5 NCAN OBSCN ROBO2 BCAN IFNLR1 CNTFR | 8.13e-05 | 706 | 85 | 12 | IPR013783 |
| Domain | C-type_lectin-like/link | 8.86e-05 | 99 | 85 | 5 | IPR016186 | |
| Domain | IG | 1.25e-04 | 421 | 85 | 9 | SM00409 | |
| Domain | Ig_sub | 1.25e-04 | 421 | 85 | 9 | IPR003599 | |
| Domain | CTDL_fold | 1.28e-04 | 107 | 85 | 5 | IPR016187 | |
| Domain | TSP_1 | 1.94e-04 | 63 | 85 | 4 | PF00090 | |
| Domain | TSP1 | 2.19e-04 | 65 | 85 | 4 | SM00209 | |
| Domain | TSP1_rpt | 2.19e-04 | 65 | 85 | 4 | IPR000884 | |
| Domain | TSP1 | 2.19e-04 | 65 | 85 | 4 | PS50092 | |
| Domain | ig | 2.30e-04 | 190 | 85 | 6 | PF00047 | |
| Domain | Immunoglobulin | 2.30e-04 | 190 | 85 | 6 | IPR013151 | |
| Domain | FN3 | 2.95e-04 | 199 | 85 | 6 | PS50853 | |
| Domain | Ig_V-set | 2.95e-04 | 199 | 85 | 6 | IPR013106 | |
| Domain | FN3_dom | 3.83e-04 | 209 | 85 | 6 | IPR003961 | |
| Domain | IG_LIKE | 3.91e-04 | 491 | 85 | 9 | PS50835 | |
| Domain | SH3 | 4.57e-04 | 216 | 85 | 6 | SM00326 | |
| Domain | SH3 | 4.57e-04 | 216 | 85 | 6 | PS50002 | |
| Domain | Ig-like_dom | 4.65e-04 | 503 | 85 | 9 | IPR007110 | |
| Domain | SH3_domain | 5.03e-04 | 220 | 85 | 6 | IPR001452 | |
| Domain | MetalloPept_cat_dom | 5.09e-04 | 81 | 85 | 4 | IPR024079 | |
| Domain | - | 5.09e-04 | 81 | 85 | 4 | 3.40.390.10 | |
| Domain | Tyr_kinase_rcpt_3_CS | 5.63e-04 | 8 | 85 | 2 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 5.63e-04 | 8 | 85 | 2 | PS00240 | |
| Domain | UBA | 5.83e-04 | 36 | 85 | 3 | PF00627 | |
| Domain | TyrKc | 6.97e-04 | 88 | 85 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 6.97e-04 | 88 | 85 | 4 | IPR020635 | |
| Domain | IGc2 | 7.11e-04 | 235 | 85 | 6 | SM00408 | |
| Domain | Ig_sub2 | 7.11e-04 | 235 | 85 | 6 | IPR003598 | |
| Domain | CYSTEINE_SWITCH | 8.56e-04 | 41 | 85 | 3 | PS00546 | |
| Domain | fn3 | 8.66e-04 | 162 | 85 | 5 | PF00041 | |
| Domain | Pept_M10_metallopeptidase | 9.84e-04 | 43 | 85 | 3 | IPR001818 | |
| Domain | C-type_lectin_CS | 9.84e-04 | 43 | 85 | 3 | IPR018378 | |
| Domain | PROTEIN_KINASE_TYR | 1.00e-03 | 97 | 85 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.00e-03 | 97 | 85 | 4 | IPR008266 | |
| Domain | ZINC_PROTEASE | 1.04e-03 | 98 | 85 | 4 | PS00142 | |
| Domain | UBA | 1.05e-03 | 44 | 85 | 3 | IPR015940 | |
| Domain | UBA | 1.28e-03 | 47 | 85 | 3 | PS50030 | |
| Domain | LINK | 1.55e-03 | 13 | 85 | 2 | SM00445 | |
| Domain | Link_dom | 1.55e-03 | 13 | 85 | 2 | IPR000538 | |
| Domain | Xlink | 1.55e-03 | 13 | 85 | 2 | PF00193 | |
| Domain | LINK_1 | 1.55e-03 | 13 | 85 | 2 | PS01241 | |
| Domain | LINK_2 | 1.55e-03 | 13 | 85 | 2 | PS50963 | |
| Domain | FN3 | 1.56e-03 | 185 | 85 | 5 | SM00060 | |
| Domain | Ig_I-set | 1.76e-03 | 190 | 85 | 5 | IPR013098 | |
| Domain | I-set | 1.76e-03 | 190 | 85 | 5 | PF07679 | |
| Domain | PLAC | 1.80e-03 | 14 | 85 | 2 | PF08686 | |
| Domain | Retrov_capsid_C | 2.46e-03 | 59 | 85 | 3 | IPR008916 | |
| Domain | Pkinase_Tyr | 2.86e-03 | 129 | 85 | 4 | PF07714 | |
| Domain | RUN | 2.99e-03 | 18 | 85 | 2 | SM00593 | |
| Domain | UBA-like | 3.10e-03 | 64 | 85 | 3 | IPR009060 | |
| Domain | RUN | 3.33e-03 | 19 | 85 | 2 | PS50826 | |
| Domain | RUN | 3.33e-03 | 19 | 85 | 2 | PF02759 | |
| Domain | Run_dom | 3.33e-03 | 19 | 85 | 2 | IPR004012 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.64e-03 | 138 | 85 | 4 | IPR001245 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.64e-05 | 250 | 64 | 8 | M27554 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.82e-05 | 39 | 64 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.82e-05 | 39 | 64 | 4 | MM15165 | |
| Pathway | REACTOME_CS_DS_DEGRADATION | 3.13e-05 | 14 | 64 | 3 | M651 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.53e-05 | 143 | 64 | 6 | M27275 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.53e-04 | 68 | 64 | 4 | M27303 | |
| Pathway | REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE | 5.58e-04 | 8 | 64 | 2 | M27260 | |
| Pathway | REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS | 5.58e-04 | 8 | 64 | 2 | M27261 | |
| Pathway | REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD | 5.58e-04 | 8 | 64 | 2 | M27259 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 2.14e-08 | 12 | 91 | 4 | 25770910 | |
| Pubmed | 2.05e-06 | 10 | 91 | 3 | 11167130 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CCDC142 LPIN3 MYOF ADAMTS7 PKD1 OBSCN AKNA MAP3K11 ZNF579 IDUA IFNLR1 ABCC10 HR | 6.06e-06 | 1105 | 91 | 13 | 35748872 |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 36614108 | ||
| Pubmed | The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis. | 6.77e-06 | 2 | 91 | 2 | 19098927 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19836009 | ||
| Pubmed | Negative effects of ADAMTS-7 and ADAMTS-12 on endplate cartilage differentiation. | 6.77e-06 | 2 | 91 | 2 | 22247065 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 24191038 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 11486035 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 21997179 | ||
| Pubmed | Whirlin complexes with p55 at the stereocilia tip during hair cell development. | 4.05e-05 | 4 | 91 | 2 | 16829577 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 29367009 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 11027579 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 31558805 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 35721494 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 20301293 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 18485748 | ||
| Pubmed | Extracellular matrix alterations in brains lacking four of its components. | 4.05e-05 | 4 | 91 | 2 | 15694392 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 23637166 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 28512860 | ||
| Pubmed | Neural extracellular matrix regulates visual sensory motor integration. | 4.05e-05 | 4 | 91 | 2 | 38318351 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 10766023 | ||
| Pubmed | Erythropoietin improves skin wound healing and activates the TGF-β signaling pathway. | 4.05e-05 | 4 | 91 | 2 | 21894148 | |
| Pubmed | E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. | 4.05e-05 | 4 | 91 | 2 | 19237537 | |
| Pubmed | 4.62e-05 | 75 | 91 | 4 | 20637190 | ||
| Pubmed | Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases. | 6.74e-05 | 5 | 91 | 2 | 26038530 | |
| Pubmed | Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis. | 6.74e-05 | 5 | 91 | 2 | 24113870 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 7.21e-05 | 84 | 91 | 4 | 15203218 | |
| Pubmed | 8.13e-05 | 32 | 91 | 3 | 9611252 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 8.96e-05 | 171 | 91 | 5 | 20201926 | |
| Pubmed | The spatiotemporal expression pattern of Syndecans in murine embryonic teeth. | 9.78e-05 | 34 | 91 | 3 | 32220631 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 17420256 | ||
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 9040657 | ||
| Pubmed | Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes. | 1.01e-04 | 6 | 91 | 2 | 30102256 | |
| Pubmed | A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease. | 1.01e-04 | 6 | 91 | 2 | 29891559 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.36e-04 | 910 | 91 | 10 | 36736316 | |
| Pubmed | 1.85e-04 | 42 | 91 | 3 | 18985028 | ||
| Pubmed | 2.41e-04 | 9 | 91 | 2 | 25314967 | ||
| Pubmed | 3.01e-04 | 10 | 91 | 2 | 20950796 | ||
| Pubmed | Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling. | 3.01e-04 | 10 | 91 | 2 | 27464987 | |
| Pubmed | 3.29e-04 | 51 | 91 | 3 | 11853319 | ||
| Pubmed | ADAMTS10 RNF31 NCAN PKD1 OBSCN RUSC1 SLC35B2 GNAS ZNF579 PAICS IFNLR1 | 3.32e-04 | 1215 | 91 | 11 | 15146197 | |
| Pubmed | Strain background effects and genetic modifiers of hearing in mice. | 3.67e-04 | 11 | 91 | 2 | 16579977 | |
| Pubmed | 4.39e-04 | 12 | 91 | 2 | 31808745 | ||
| Pubmed | CIB2 interacts with TMC1 and TMC2 and is essential for mechanotransduction in auditory hair cells. | 4.39e-04 | 12 | 91 | 2 | 28663585 | |
| Pubmed | 4.47e-04 | 242 | 91 | 5 | 34011540 | ||
| Pubmed | Mapping of the syndecan genes in the mouse: linkage with members of the myc gene family. | 5.18e-04 | 13 | 91 | 2 | 7959737 | |
| Pubmed | Class III myosins shape the auditory hair bundles by limiting microvilli and stereocilia growth. | 6.04e-04 | 14 | 91 | 2 | 26754646 | |
| Pubmed | Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly. | 6.04e-04 | 14 | 91 | 2 | 16903783 | |
| Pubmed | Genetic mutations associated with cigarette smoking in pancreatic cancer. | 6.14e-04 | 63 | 91 | 3 | 19351817 | |
| Pubmed | 6.85e-04 | 733 | 91 | 8 | 34672954 | ||
| Pubmed | Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. | 6.95e-04 | 15 | 91 | 2 | 11698403 | |
| Pubmed | Muscleblind-like 1 is required for normal heart valve development in vivo. | 6.95e-04 | 15 | 91 | 2 | 26472242 | |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 6.95e-04 | 15 | 91 | 2 | 38871984 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 7.16e-04 | 925 | 91 | 9 | 28986522 | |
| Pubmed | 8.85e-04 | 162 | 91 | 4 | 25826454 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 9.49e-04 | 430 | 91 | 6 | 35044719 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 1.01e-03 | 18 | 91 | 2 | 35503090 | |
| Pubmed | 1.12e-03 | 19 | 91 | 2 | 29618652 | ||
| Pubmed | 1.12e-03 | 19 | 91 | 2 | 21508241 | ||
| Pubmed | 1.37e-03 | 83 | 91 | 3 | 11114734 | ||
| Pubmed | 1.38e-03 | 21 | 91 | 2 | 23707896 | ||
| Pubmed | Jak2 is essential for signaling through a variety of cytokine receptors. | 1.38e-03 | 21 | 91 | 2 | 9590173 | |
| Pubmed | 1.38e-03 | 21 | 91 | 2 | 8499630 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 1.38e-03 | 1016 | 91 | 9 | 19056867 | |
| Pubmed | 1.47e-03 | 85 | 91 | 3 | 15449545 | ||
| Pubmed | Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. | 1.51e-03 | 22 | 91 | 2 | 9324354 | |
| Pubmed | 1.51e-03 | 22 | 91 | 2 | 9811459 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.60e-03 | 1038 | 91 | 9 | 26673895 | |
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 1.65e-03 | 23 | 91 | 2 | 10708515 | |
| Pubmed | 1.80e-03 | 24 | 91 | 2 | 21037509 | ||
| Pubmed | 1.80e-03 | 24 | 91 | 2 | 25344368 | ||
| Pubmed | 1.80e-03 | 24 | 91 | 2 | 17366632 | ||
| Pubmed | 1.84e-03 | 92 | 91 | 3 | 20368287 | ||
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 1.96e-03 | 94 | 91 | 3 | 23431145 | |
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 2.11e-03 | 26 | 91 | 2 | 33905568 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.40e-03 | 101 | 91 | 3 | 23382219 | |
| Pubmed | 2.40e-03 | 101 | 91 | 3 | 10997877 | ||
| Pubmed | 2.45e-03 | 28 | 91 | 2 | 26884322 | ||
| Pubmed | 2.45e-03 | 28 | 91 | 2 | 18593464 | ||
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 2.45e-03 | 28 | 91 | 2 | 24462114 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 6.07e-04 | 1192 | 91 | 9 | chr19q13 | |
| Cytoband | 20q13.3 | 7.21e-04 | 20 | 91 | 2 | 20q13.3 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.87e-07 | 19 | 55 | 4 | 50 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.43e-05 | 4 | 55 | 2 | 574 | |
| GeneFamily | Fibronectin type III domain containing | 1.24e-04 | 160 | 55 | 5 | 555 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.43e-04 | 40 | 55 | 3 | 321 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.62e-04 | 41 | 55 | 3 | 1298 | |
| GeneFamily | Immunoglobulin like domain containing | 2.97e-04 | 193 | 55 | 5 | 594 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.04e-03 | 27 | 55 | 2 | 1253 | |
| GeneFamily | C-type lectin domain family | 9.00e-03 | 47 | 55 | 2 | 494 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.30e-02 | 161 | 55 | 3 | 593 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.30e-02 | 57 | 55 | 2 | 1179 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.34e-02 | 163 | 55 | 3 | 590 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | SSC5D MAP1A ADAMTS7 AXL NCAN AKNA ZKSCAN2 PHYHD1 FUCA1 ADGRV1 ZNF579 MGAT5B TBCE | 9.68e-06 | 732 | 88 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-07 | 192 | 90 | 7 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.44e-07 | 155 | 90 | 6 | 5d157478669b609e1f0f0a75afd0112571fc2c46 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-06 | 167 | 90 | 6 | 942134bbabe9972fae80cbc4ed4e94da52f55dc3 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-06 | 172 | 90 | 6 | 9befd44bce43eb5dc1fe3d2e44608f442cf74a47 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-06 | 184 | 90 | 6 | 65b00145cb7da7d64eb6765569573c1a902a1036 | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 2.43e-06 | 190 | 90 | 6 | e9507bb0c8ff3d071402731a9b8cfe1bba93fab0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-06 | 193 | 90 | 6 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-06 | 193 | 90 | 6 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Tpbg_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.21e-06 | 50 | 90 | 4 | 9a54cd5a55ef53f7a8b43fe76c4e0e47b44b8c71 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Tpbg_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.21e-06 | 50 | 90 | 4 | cd5e2a8f4fa4a31d0c7a74d5826485e42b3908f7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 200 | 90 | 6 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.93e-06 | 122 | 90 | 5 | 489a01c71882be5a6d71a19d06574698988c20f6 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.93e-06 | 122 | 90 | 5 | 7dabf8b4c34a3714f45c3a99c1aa159e2d0b7e9c | |
| ToppCell | control-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.18e-05 | 146 | 90 | 5 | 69e9c1ec6eec1151290227902e75e77a4aecc8db | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-05 | 151 | 90 | 5 | 2f9b3e14c2fa6e2b1976ca6ab2031b63bf5e3e64 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.84e-05 | 160 | 90 | 5 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 161 | 90 | 5 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 161 | 90 | 5 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-05 | 167 | 90 | 5 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.39e-05 | 169 | 90 | 5 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-05 | 169 | 90 | 5 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.39e-05 | 169 | 90 | 5 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 2.46e-05 | 170 | 90 | 5 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 2.53e-05 | 171 | 90 | 5 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 174 | 90 | 5 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-05 | 174 | 90 | 5 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | mild-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.91e-05 | 176 | 90 | 5 | 59a9c262c252b7d220a025837922d98e9d6b0a24 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 176 | 90 | 5 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.07e-05 | 178 | 90 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 181 | 90 | 5 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.32e-05 | 181 | 90 | 5 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-05 | 182 | 90 | 5 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-05 | 182 | 90 | 5 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-05 | 182 | 90 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-05 | 182 | 90 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 3.50e-05 | 183 | 90 | 5 | c94ee9f35b21252e1ab5ab15b6a2ce69a7d753f7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 185 | 90 | 5 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 185 | 90 | 5 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 185 | 90 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 185 | 90 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 185 | 90 | 5 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 185 | 90 | 5 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.78e-05 | 186 | 90 | 5 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.78e-05 | 186 | 90 | 5 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.78e-05 | 186 | 90 | 5 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.78e-05 | 186 | 90 | 5 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-05 | 187 | 90 | 5 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-05 | 187 | 90 | 5 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-05 | 187 | 90 | 5 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-05 | 187 | 90 | 5 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-pDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.88e-05 | 187 | 90 | 5 | bf64a6ef5062ec9a0f7095e8c97ce66bfc3bf179 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 4.08e-05 | 189 | 90 | 5 | aac79c41ce7acba722c45c016b2c6997fb772a96 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.19e-05 | 190 | 90 | 5 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.29e-05 | 191 | 90 | 5 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.51e-05 | 193 | 90 | 5 | bdbbfcbe339f23a88dfcc59d53c034bac1605b07 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.51e-05 | 193 | 90 | 5 | acafe177cd05b2966f5fa26ea02f420f13f2cee5 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 194 | 90 | 5 | 8e2819a9d0529f7b2de1a7c1190575175d6173ee | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.62e-05 | 194 | 90 | 5 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.74e-05 | 195 | 90 | 5 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.97e-05 | 197 | 90 | 5 | 0a22686d586c0334a2fd872a28e26b75693234cf | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.09e-05 | 198 | 90 | 5 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.22e-05 | 199 | 90 | 5 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Caecum-Dendritic_cell|Caecum / Region, Cell class and subclass | 5.34e-05 | 200 | 90 | 5 | b91d3d7505a022ca360ab5b3f9955753d111f974 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 200 | 90 | 5 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 200 | 90 | 5 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Caecum-(5)_Dendritic_cell|Caecum / shred on region, Cell_type, and subtype | 5.34e-05 | 200 | 90 | 5 | aa87810706fd4164085d8e973359b68a2691842e | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.34e-05 | 200 | 90 | 5 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.91e-05 | 104 | 90 | 4 | 11d91471b6c4fa6b00a91d9fd4db72ee60d1f801 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.91e-05 | 104 | 90 | 4 | 424a58b04c8b5108b70f15d8353c8e4b9db1e730 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.91e-05 | 104 | 90 | 4 | 9b05ae514437eb0c8b1b23607ae8cbc371ffa85b | |
| ToppCell | (50)_cDC2|World / shred on Cell_type and subtype | 6.14e-05 | 206 | 90 | 5 | d519adeb8290fcce107e81a439ba3bf1e231b55b | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.10e-04 | 122 | 90 | 4 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 126 | 90 | 4 | 83f3540683b3b175b10af059ab8898c46eaccc13 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 126 | 90 | 4 | 6d5075d659dac7b96e6857f8485a7d2c4105d685 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 126 | 90 | 4 | fd0001a0f3a0a4421f96fd21813c21cf6f01d40e | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 126 | 90 | 4 | f20424f9baf3c4059cd6b701761e7595400fc47c | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Cadm1_(Cerebellum_basket_cells_3)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 51 | 90 | 3 | 0611419cc63dbe772d10c1f6f96826786351f048 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Cadm1_(Cerebellum_basket_cells_3)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 51 | 90 | 3 | a673b6d6ddecb7c239cb49ff490188460edc87e0 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.81e-04 | 139 | 90 | 4 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 153 | 90 | 4 | d5f5399ebbbff508c96ce7f01272716b61597ab5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 153 | 90 | 4 | 32cf4ca828d228f23366480305592f9813fed7ff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 155 | 90 | 4 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 157 | 90 | 4 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.89e-04 | 157 | 90 | 4 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 157 | 90 | 4 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-04 | 159 | 90 | 4 | 141c3ed35c7d11fcaec4acd9cb37104cc259db25 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Th_Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.09e-04 | 65 | 90 | 3 | c336aa3501b9576bf12ef1bbefae55fff7705662 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.10e-04 | 160 | 90 | 4 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.10e-04 | 160 | 90 | 4 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.10e-04 | 160 | 90 | 4 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-04 | 161 | 90 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-04 | 161 | 90 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-04 | 161 | 90 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-04 | 162 | 90 | 4 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 3.25e-04 | 162 | 90 | 4 | e088e66aabc307dde5d2b9aa295c34ef68155b1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-04 | 162 | 90 | 4 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A | 9.79e-07 | 195 | 89 | 8 | 1884_UP | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; HL60; HG-U133A | 1.19e-05 | 196 | 89 | 7 | 1770_UP | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; HL60; HG-U133A | 1.23e-05 | 197 | 89 | 7 | 1749_UP | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; HL60; HG-U133A | 1.28e-05 | 198 | 89 | 7 | 2042_UP | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 5.26e-05 | 4 | 88 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 5.26e-05 | 4 | 88 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | cortical thickness | VPS13D ZBTB32 ADAMTS7 PROX2 PKD1 ROBO2 TMEM131 ADGRV1 IDUA KIAA1614 ABCC10 TG | 1.14e-04 | 1113 | 88 | 12 | EFO_0004840 |
| Disease | IGF-like family receptor 1 measurement | 1.31e-04 | 6 | 88 | 2 | EFO_0801687 | |
| Disease | mean fractional anisotropy measurement | 1.91e-04 | 95 | 88 | 4 | EFO_0008399 | |
| Disease | high grade glioma (implicated_via_orthology) | 3.11e-04 | 44 | 88 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Liver Diseases, Parasitic | 3.12e-04 | 9 | 88 | 2 | C0023897 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 3.90e-04 | 10 | 88 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 4.75e-04 | 11 | 88 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | Sclerocystic Ovaries | 9.23e-04 | 144 | 88 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 9.23e-04 | 144 | 88 | 4 | C0032460 | |
| Disease | Nonsyndromic Deafness | 1.85e-03 | 81 | 88 | 3 | C3711374 | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.33e-03 | 24 | 88 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.33e-03 | 24 | 88 | 2 | C3805278 | |
| Disease | carpal tunnel syndrome | 2.42e-03 | 89 | 88 | 3 | EFO_0004143 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 2.73e-03 | 26 | 88 | 2 | EFO_0007870 | |
| Disease | Cholangiocarcinoma | 2.73e-03 | 26 | 88 | 2 | C0206698 | |
| Disease | creatinine measurement | 2.87e-03 | 995 | 88 | 9 | EFO_0004518 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SWSPEPSVVPDQAWE | 76 | P84996 | |
| GWPWLLPDGSPVDIF | 456 | Q6P1J9 | |
| EPWGLIPPTTAGWEE | 1066 | Q8IUX7 | |
| LWTFPSPGWPEAFVL | 4961 | Q8WXG9 | |
| SQLLGSWDPWEEPED | 171 | Q96CA5 | |
| SGGTPWWPTPADVSE | 51 | Q17RM4 | |
| ESEWGLDTPPGWPAA | 366 | O14678 | |
| TEPCPPDWVVGNWSL | 881 | Q9H324 | |
| GPTCPPEWAALDWSE | 941 | Q9H324 | |
| LAPPLTPDLSRESWW | 1196 | P58397 | |
| TPDLSRESWWPPFST | 1201 | P58397 | |
| TPIPEHVDGDWSPWG | 536 | Q8TE56 | |
| WENLTSPGPTKEPVW | 776 | Q9UKP4 | |
| EEGVLGPWSPSPWPS | 1121 | Q9UKP4 | |
| ADFPWELDPDWSPSP | 81 | Q32P28 | |
| DEALWAWPSELSSPG | 476 | Q96GW7 | |
| SSAAWPLPLWEGDTT | 11 | Q5T3U5 | |
| WSWATLEVPVPTGQP | 346 | Q9BQK8 | |
| NEPTTPSWLADIPPW | 1831 | P78559 | |
| PEDNLSSWATWGTLP | 441 | Q8IU57 | |
| SSWATWGTLPPEPNL | 446 | Q8IU57 | |
| SETPWTVPPLAPSWD | 916 | Q9UKN7 | |
| LSLRGSWEEVGPPSW | 1186 | Q9UKN7 | |
| PDDLTASWPDWALPR | 41 | Q9UJY1 | |
| WPPEAEWTLPDHDRG | 186 | Q5VZ46 | |
| PAWTPSWDTAAPERP | 321 | Q5VZ46 | |
| PAPFWRGVLSTPDSW | 46 | O43593 | |
| LFLGQPDTVPWTSWP | 266 | O43593 | |
| EWARNTSLAPGAWPP | 671 | Q3V5L5 | |
| DDSDCPRSWTWPEGP | 411 | Q9UMF0 | |
| PRSWTWPEGPEQTLR | 416 | Q9UMF0 | |
| WPSLDSRPLPAWFDE | 41 | P04066 | |
| LSQSPLDPRSWTEPW | 396 | Q8WWR8 | |
| PSYPWLWEDGSPLMP | 211 | P78380 | |
| LDADPWLPAWTPENS | 321 | C9JSJ3 | |
| SGWEPPVDVLQEAPW | 421 | Q9H6S3 | |
| APEERPRAPWWDTSS | 226 | P51843 | |
| PRAPWWDTSSGALRP | 231 | P51843 | |
| AEFPEPTWPWPGELG | 7346 | Q5VST9 | |
| SPTAPGTWAAAWVPL | 46 | Q9UHM6 | |
| PWSQVPSSSPTDPEW | 41 | Q3B8N5 | |
| SWGLPAMDSWPPEDP | 101 | Q6UXA7 | |
| SSESWPIPEPEWPAQ | 171 | Q6ZRC1 | |
| GSVEWDGPPSPHWTL | 46 | P07333 | |
| AEWAEPWDGAVFRPP | 36 | Q495W5 | |
| WQTPSTWPDPESFPL | 226 | P26992 | |
| SPVRPPVSTWGPSWA | 31 | Q9NUB4 | |
| PWGAPIIWDGSFDPD | 76 | U3KPV4 | |
| RSAEWWPGPAEDPQA | 506 | Q7Z591 | |
| PWEWGEKGISTPRPE | 201 | Q9HDB8 | |
| SGPEHPELWRLWPDT | 221 | Q9HDB8 | |
| DPLVGWSLPQPWRAD | 301 | P35475 | |
| SDPWTPAPAFSDPWG | 366 | Q9Y6I3 | |
| WWSPCTPFTEDPPAS | 316 | P19235 | |
| SGPTHWVPWISPETT | 161 | A4GXA9 | |
| SGQSIPWDLWEPTES | 411 | O00499 | |
| PWDLWEPTESPAGSL | 416 | O00499 | |
| PPSEWASRFGIWAPL | 186 | Q8N813 | |
| APWTLFPDSDPFWDS | 801 | Q16584 | |
| TWSPENWLQPTAELP | 271 | Q5SRE7 | |
| WPSGEGTLSWPDLLS | 3411 | P98161 | |
| DPSDSPNLPTPGSWW | 716 | Q9BVN2 | |
| EVEVPLDTWDWGSEP | 366 | Q8IYJ3 | |
| LDTWDWGSEPTWLPL | 371 | Q8IYJ3 | |
| DFPPLPTDWAWEAVN | 51 | Q8NHS9 | |
| PTDWAWEAVNPELAP | 56 | Q8NHS9 | |
| PSTQPRPDSWGEDNW | 746 | Q96KG9 | |
| SPRPWTPEDPWSLYG | 221 | Q14934 | |
| EENPGLSWTDWPEPS | 336 | Q9BWX1 | |
| LSWTDWPEPSLLEKP | 341 | Q9BWX1 | |
| WPTGEVWLSTVAPSP | 441 | O14594 | |
| TPADFWWLQSDSPDP | 126 | Q2NL68 | |
| RNDTFSDSPVWPWIP | 836 | Q8IX21 | |
| SDSPVWPWIPSLSDV | 841 | Q8IX21 | |
| PDSLWDWTVAPPVPA | 41 | Q01892 | |
| PPWTWDPTSREDLAK | 881 | A1L4H1 | |
| LPWTWDTPSGRGLAE | 936 | A1L4H1 | |
| QGTWVPWSQDAPESP | 161 | Q8N4L4 | |
| WLWQDGSSPSPGLLP | 186 | Q6UXN8 | |
| SERPWPSPWPSGLAS | 86 | Q3C1V1 | |
| LWSHWEDSALPPPSL | 246 | Q9Y3P4 | |
| RQRLWDSGPEPTPSW | 621 | Q96EP0 | |
| PPLTPDWGVQDVWSS | 351 | P22234 | |
| SEDLPLPPGWSVDWT | 196 | Q9H4B6 | |
| PVAGPWLGVEWDNPE | 31 | Q15813 | |
| GETPEAPPESWTQLW | 21 | Q8TB61 | |
| DLPPLNPTSWWADLR | 251 | Q9H2V7 | |
| WESPATDPSPSWPAS | 1766 | Q92545 | |
| PLEWAWPGAQEAPAT | 56 | P35916 | |
| GPSSWTHWLPVETPE | 316 | P30530 | |
| PGTEPLGTTKWLWEP | 291 | Q9Y6I9 | |
| TKSPWEPDGLPLLEW | 706 | Q8TBZ2 | |
| MGEAPSPAPALWDWD | 1 | Q2T9K0 | |
| YPWLADSWPATSLPV | 921 | Q9HCK4 | |
| PSSLSWAPSAEQWLP | 651 | O15040 | |
| EPWEEPQWVTSPLHS | 906 | Q2M1Z3 | |
| WEPARWDTTLPTPSP | 466 | Q2NKQ1 | |
| TSFPAPSEPSAPGWW | 546 | O43151 | |
| QWDPPTWESPGDDAS | 2416 | Q9BYW2 | |
| QGSPARWSEPWVPVE | 1386 | O43379 | |
| RGEAPWGPDPWDTEI | 66 | Q6ZSS3 | |
| WGPDPWDTEILRGIS | 71 | Q6ZSS3 | |
| ARPSPWVPALADEWN | 196 | Q63HK3 | |
| TSVTPRPSWAEAPWL | 241 | Q9Y2Y4 | |
| AVAAWPETWPAGEPS | 166 | Q8NAF0 | |
| LWSDPEDTTGWGVSP | 196 | P60510 | |
| PEPLNWTGSWDASKP | 2246 | P01266 | |
| LSGWEPFIEPWPCSV | 2761 | Q5THJ4 | |
| AASPSELTCPPGWEW | 961 | Q9NZM1 |